-
Clinical Research News | A multinational, placebo-controlled phase 2 trial will test whether cabergoline, an inexpensive, off-patent drug that suppresses lactation, can lower breast cancer risk in young women who carry BRCA1 pathogenic variants. The idea is to give the drug once these women have decided to wean. more...
November 19, 2026
-
Clinical Research News | Oracle today announced Oracle Life Sciences AI Agents for clinical trial operations. By bringing together insights from Oracle Life Sciences applications and supported third-party data sources, the agents are designed to help clinical trial teams identify operational issues, recommend appropriate actions for review and approval, and coordinate responses across clinical development workflows. more...
November 18, 2026
-
Clinical Research News | Clinical research teams have spent years trying to shorten the wait between a promising therapeutic idea and the first participant visit. When those efforts succeed, they will create a different bottleneck: sites asked to move faster through screening, documentation, and activation with no additional room for ambiguity. I would like sponsors to start measuring one thing before celebrating an accelerated timeline: whether the site can explain and correct the critical decisions made along the way. more...
November 17, 2026
-
Clinical Research News | As consumer health wearables move closer to medical territory, product makers need clinical data that supports their claims, whether or not they plan to seek FDA clearance, according to regulatory and clinical research experts at DCN Dx. more...
November 12, 2026
-
Clinical Research News | Implementing an artificial intelligence (AI) policy at the highest levels of a clinical research organization requires middle managers empowered and equipped to carry it out companywide. But not every AI workflow deserves the same level of scrutiny, according to Marc Wartenberger, vice president of compliance and security at CRIO, who moderated a panel discussion on the policy-to-practice issues at the recent SCOPE Europe event in Barcelona. more...
November 10, 2026
-
Clinical Research News | For any life sciences organization keen to establish appropriate guardrails around their AI use, recent debate about preventing AI’s potential harms has helped frame some of the critical parameters. Previously, too much of the “trusted AI” discussion has centered on the ability to explain how AI has arrived at its conclusions. But this quality alone does not make for robust governance, especially where patient safety is at stake. more...
November 06, 2026
-
Clinical Research News | Flatiron Health is building a global oncology intelligence engine that is poised to change how research gets done by scaling data collection and speeding up how researchers extract evidence. The platform, known as Flatiron Telescope, is designed to enable anyone working in oncology to answer questions faster at any stage of drug development. more...
November 05, 2026
-
Clinical Research News | KymaThera's $80M Series B carries K-1728 into Phase 1; Microbiotica raises £36M to take MB310 into Phase 2 for ulcerative colitis; Altay Therapeutics closes $37M for Phase 1 and Phase 2 trials in FSHD; and more. more...
October 28, 2026
-
Clinical Research News | Peppermint raises $4.7 million to speed payments to clinical trial sites; Clinisys adds document intelligence to its laboratory platform; and more. more...
October 27, 2026
-
Clinical Research News | Advocate Health, one of the largest health systems in the U.S., is extending its “care for all” mission to clinical research with the building of an organization-wide National Center for Clinical Trials (NCCT) focused on supporting and accelerating industry-funded studies. The initiative launched last November and encompasses 69 hospitals and over 1,000 care sites across eight states, collectively serving nearly 6 million patients, according to NCCT President Adam Samson. more...
October 22, 2026